Analyst Ratings for Editas Medicine (EDIT)
EDIT Rating Summary
EDIT Price Target Summary
- Highest: $15.00 (Evercore ISI)
- Lowest: $4.00 (Wells Fargo)
- Average: $6.94
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$6.94 (+126.2%)
* Over Last 12-Mos
Rating Score: 4.3 / 10
Percentile Rank: 43%
Avg. $ Target:
$6.94 (+126.2%)
* Over Last 12-Mos
Rating Score: 4.3 / 10
Percentile Rank: 43%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/18/2026 | Ladenburg Thalmann | N/A | New Coverage | Buy (N/A) |
6.00 (N/A) |
2.84 (3.07) |
8.1% | Details |
| 4/6/2026 | Jones Trading | Boris Peaker | New Coverage | Buy (N/A) |
8.00 (N/A) |
2.67 (3.07) |
14.98% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
